Orloff John J

EVP, Research & Development at ALEXION PHARMACEUTICALS INC

Sold, on record
$251k
Dollars the filings state
Form 4 sales
1
Latest Jun 8, 2018
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not stated
    Jun 8, 2018 2018

    Sold 2,115 shares at $118.53 ($251k)

    Orloff John J, EVP, Research & Development

    Sold 6.2% of holdings ($4M position)31,790 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Orloff John J
Source
Jun 8, 2018Jun 12, 2018ALEXION PHARMACEUTICALS INCEVP, Research & DevelopmentForm 4 sale2,115$251k6.2%Plan not statedSEC